Investor

ROI and Clinical Validation Will Be the Greatest Markers of Success in 2023 According to Top Digital Health Investors

Investors in the healthcare technology space believe a measurable return on investment (ROI) and clinical validation of the technology’s platform will be the greatest indicators of company success in 2023, according to a new survey of top digital health investors by GSR Ventures. ROI was deemed “important” or “very important” to the success of digital health companies by more than 94% of investor respondents,…

Internationalization: How VCs Are Supporting European Femtech Startups with U.S. Market Entry

“Just call us America’s sweethearts!” shared the HANX team on Twitter a few weeks ago as they proudly announced their expansion plans and launch in the U.S. The sexual health company, that offers intimate care products like vegan condoms and lube, but also oral contraceptives delivered to your doorstep, was founded in the UK in 2017 and has now made the move…

VCs For Repro: 100+ VC Firms Take a Stand on Reproductive Rights Ahead of Midterm Elections in the U.S.

“Women’s ability to participate freely and fully in the workforce is essential to the growth, performance and resilience of the U.S. economy and the businesses which comprise it. Their participation is contingent upon access to comprehensive reproductive health services, including contraception and abortion. These services are used by nearly all women – 99 percent have used contraception and 25 percent have had…

RH Capital Raises over $40M to Tackle Reproductive and Maternal Health Equity in the U.S. 

RH Capital has just closed their oversubscribed second fund, bringing total assets under management to over $40 million to tackle reproductive and maternal health equity.  In 2019, RH Capital raised a small proof of concept fund with around $5M and has now closed fund II with an additional $38.5M. The fund’s lead investors include Tara Health Foundation, Skoll Foundation, The Impact Seat…

Women’s Health Fund Coyote Ventures Receives Investment from Bank of America

Coyote Ventures, a women’s health focused early stage ventures fund has announced that it has received LP investment from the Bank of America. The firm is led by General Partner Jessica Karr and has made 6 investments to date. Portfolio companies include Wile (hormone health), Hera Biotech (endometriosis diagnostics), O.School (sexual wellness), Flex (cycle care), Gabbi (breast cancer diagnostics), and Maude (sexual…

True Wealth Ventures Raises $35 Million for Fund II to Invest in Women-Led Companies

True Wealth Ventures has closed its second fund fund to invest in women-led startups addressing the world’s most pressing issues in human and environmental health. The $35M Fund II close follows True Wealth Ventures’ 2018 $19.1M Fund I close. Fund I’s 80% women limited partners was unprecedented. True Wealth’s total AUM is now about $60M. Founding General Partner Sara Brand and General Partner Kerry Rupp lead True…

Magnify Ventures Closes a $52M Fund to Invest in the Digital Transformation of the Care Economy

Magnify Ventures, an early-stage venture capital firm investing in founders leading the digital transformation of how we live, work and care for one another, is announcing a $52M fund. The firm will invest in early-stage technology companies that are revolutionizing the care economy in four growing categories, including parenting and family life, the future of work, household optimization, and aging and longevity. Julie Wroblewski, Magnify Ventures’…

Seed Stage Fund Emmeline Ventures Launches with Plans to Invest in Femtech, Fintech and Sustainability

La Keisha Landrum Pierre, Naseem Sayani, and Azin Radsan van Alebeek initially met in 2020 when they were part of the same cohort of Pipeline Angels, an angel investing program focused “changing the face of VC” and creating capital underrepresented founders. Shortly after they started investing together and have made 13 angel investments to date into companies that help women, in particular,…